Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Read More
In a recent interview, Cipla's MD and Global CEO, Umang Vohra, declared that India was in the throes of "incredible amounts of deepening of the healthcare market into tier two and six towns." ...
To provide holistic development of students and to match Industry expectations of the pharma sector, Sri Aurobindo Institute of Pharmacy organized the 2nd HR Summit on the theme -- 'Scientific Excellence to Employability: A Pharma HR Perspective' on ...
Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment. ...
On World COPD Day, India's first pneumotach-based portable wireless spirometer to diagnose Chronic Obstructive Pulmonary Disorder (COPD) and asthma was launched by pharmaceutical major Cipla. ...
